首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   189315篇
  免费   33051篇
  国内免费   2579篇
耳鼻咽喉   5462篇
儿科学   6062篇
妇产科学   2997篇
基础医学   8063篇
口腔科学   2482篇
临床医学   29237篇
内科学   56885篇
皮肤病学   8095篇
神经病学   17430篇
特种医学   7682篇
外科学   48067篇
综合类   413篇
现状与发展   72篇
预防医学   8230篇
眼科学   3766篇
药学   3804篇
中国医学   141篇
肿瘤学   16057篇
  2024年   701篇
  2023年   4998篇
  2022年   1624篇
  2021年   3850篇
  2020年   6440篇
  2019年   2719篇
  2018年   8092篇
  2017年   7886篇
  2016年   9009篇
  2015年   9106篇
  2014年   16366篇
  2013年   16636篇
  2012年   7126篇
  2011年   7229篇
  2010年   11290篇
  2009年   14976篇
  2008年   7309篇
  2007年   5616篇
  2006年   8061篇
  2005年   5414篇
  2004年   4726篇
  2003年   3592篇
  2002年   3682篇
  2001年   5421篇
  2000年   4594篇
  1999年   4723篇
  1998年   4156篇
  1997年   3879篇
  1996年   3725篇
  1995年   3529篇
  1994年   2258篇
  1993年   1844篇
  1992年   2353篇
  1991年   2325篇
  1990年   1851篇
  1989年   2064篇
  1988年   1778篇
  1987年   1541篇
  1986年   1618篇
  1985年   1386篇
  1984年   975篇
  1983年   893篇
  1982年   703篇
  1981年   586篇
  1980年   492篇
  1979年   614篇
  1978年   567篇
  1977年   606篇
  1975年   485篇
  1972年   459篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
131.
132.
133.
134.
PURPOSE: The aim of this study is (1) to develop a new method of risk classification for clinically localized prostate cancer; (2) to examine it in terms of compatibility with existing data such as nomograms; and (3) to compare it with existing risk-grouping methods. MATERIAL AND METHODS: The new grading system introduced here consists of three factors. The first is a prostate-specific antigen (PSA) of 4.1-10.0 ng/ml (score 0), 10.1-20.0 ng/ml (score 1), and >20.0 ng/ml (score 2). The second is a Gleason score (GS) of 6 (score 0), 7 (score 1), and 8-10 (score 2). The third is T classifications (UICC 2002) of T1c-T2a (score 0), T2b-T2c (score 1), and T3a (score 2). The sum of the three scores was named Prostate Risk Index (PRIX). Then, the compatibility of PRIX with the Partin Table, Kattan Nomogram, and Roach's formula was examined. At the same time, PRIX was compared with D'Amico, the National Comprehensive Cancer Network (NCCN), and Seattle classifications. RESULTS: PRIX 0 corresponded to 1-2% of pathologic lymph node involvement (pLN+) according to the Partin Table; PRIX 1 to 3-4%; PRIX 2 to 7-10%; PRIX 3 to 14-18%; PRIX 4 to 24-29%; PRIX 5 to 32-37%; and PRIX 6 to 42%. PRIX well separated the risks with relatively narrow ranges of probability, while D'Amico, NCCN, and Seattle classifications generally gave wide ranges especially for high-risk groups, both in the Partin Table and Kattan Nomogram. Roach's formula sometimes overestimated the risk compared to the Partin Table. CONCLUSION: PRIX fully corresponded to the Partin Table in terms of pLN+, and corresponded to the other nomograms better than any existing risk-grouping method. PRIX may thus function as a prognostic factor or contribute to patient selection in clinically localized prostate cancer.  相似文献   
135.
Four Chinese patients (2 boys, 2 girls), ages 4–9 years, who had episodes of perception error of body schema and objects are reported. The metamorphopsia, which had been named Alice in Wonderland syndrome, is the major presentation. All of them were proved to have acute Epstein-Barr virus infection, as documented by positive heterophil antibody test and/or positive IgM antibody to Epstein-Barr virus capsid antigen. The duration of the perception disorder ranged from 1 week to 3 months. We believe that any young child presenting with Alice in Wonderland syndrome should undergo examination for Epstein-Barr virus infection; complete recovery from the disorder can be expected.  相似文献   
136.
137.
138.
139.
140.
The red eye     
A red eye is a cardinal sign of ocular inflammation. Most cases are benign and can be managed by the primary care provider. The key is recognizing cases requiring ophthalmological consultation by differentiating between ciliary and conjunctival injection. Ciliary injection indicates inflammation of the cornea, iris, or ciliary body, whereas conjunctival injection mainly affects the posterior conjunctival blood vessels. The author has stated that he does not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article. The author also does not discuss the use of off-label products, which includes unlabeled, unapproved, or investigative products or devices.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号